This Article Full Text Full Text (PDF) All Versions of this Article: 43/2/358    most recent 01.HYP.0000113294.06704.64v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goodfriend, T. L. Articles by Nithipatikom, K. Search for Related Content PubMed PubMed Citation Articles by Goodfriend, T. L. Articles by Nithipatikom, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LINOLEIC ACID Related Collections Lipids Obesity Other hypertension Hypertension - basic studies Lipid and lipoprotein metabolism Oxidant stress

(Hypertension. 2004;43:358.)
© 2004 American Heart Association, Inc.

Scientific Contribution

Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion

Theodore L. Goodfriend; Dennis L. Ball; Brent M. Egan; William B. Campbell; Kasem Nithipatikom

From the William S. Middleton Memorial Veterans Hospital and Departments of Medicine and Pharmacology of the University of Wisconsin (T.L.G., D.L.B.); Madison; Department of Medicine (B.M.E.), Medical University of South Carolina, Charleston; and Department of Pharmacology (W.B.C., K.N.), Medical College of Wisconsin, Milwaukee.

Correspondence to Theodore L. Goodfriend, MD, Associate Chief of Staff for Research, Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705. E-mail theodore.goodfriend{at}med.va.gov

Plasma levels of aldosterone are not always predictable from the activity of renin and the concentration of potassium. Among the unexplained are elevated levels of aldosterone in some obese humans. Obesity is characterized by increased plasma fatty acids and oxidative stress. We postulated that oxidized fatty acids stimulate aldosteronogenesis. The most readily oxidized fatty acids are the polyunsaturated, and the most abundant of those is linoleic acid. We tested oxidized derivatives of linoleic acid for effects on rat adrenal cells. One derivative, 12,13-epoxy-9-keto-10(trans)-octadecenoic acid (EKODE), was particularly potent. EKODE stimulated aldosteronogenesis at concentrations from 0.5 to 5 µmol/L, and inhibited aldosteronogenesis at higher doses. EKODE’s stimulatory effect was most prominent when angiotensin and potassium effects were submaximal. The lipid’s mechanism of action was on the early pathway leading to pregnenolone; its action was inhibited by atrial natriuretic peptide. Plasma EKODE was measured by liquid chromatography/mass spectrometry. All human plasmas tested contained EKODE in concentrations ranging from 10^-9 to 5x10^-7 mol/L. In samples from 24 adults, levels of EKODE correlated directly with aldosterone (r=0.53, P=0.007). In the 12 blacks in that cohort, EKODE also correlated with body mass index and systolic pressure. Those other correlations were not seen in white subjects. The results suggest that oxidized derivatives of polyunsaturated fatty acids other than arachidonic are biologically active. Compounds like EKODE, derived from linoleic acid, may affect adrenal steroid production in humans and mediate some of the deleterious effects of obesity and oxidative stress, especially in blacks.

Key Words: fatty acids • oxidative stress • hypertension • aldosterone • obesity • adrenal gland

This article has been cited by other articles:

				E. Ritz and A. Tomaschitz Aldosterone, a vasculotoxic agent--novel functions for an old hormone Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2302 - 2305. [Full Text] [PDF]

				J. R. Sowers, A. Whaley-Connell, and M. Epstein Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension Ann Intern Med, June 2, 2009; 150(11): 776 - 783. [Abstract] [Full Text] [PDF]

				S. Kopprasch, J. Pietzsch, I. Ansurudeen, J. Graessler, A. W Krug, M. Ehrhart-Bornstein, and S. R Bornstein Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion J. Endocrinol., January 1, 2009; 200(1): 45 - 52. [Abstract] [Full Text] [PDF]

				A. W. Krug and M. Ehrhart-Bornstein Aldosterone and Metabolic Syndrome: Is Increased Aldosterone in Metabolic Syndrome Patients an Additional Risk Factor? Hypertension, May 1, 2008; 51(5): 1252 - 1258. [Full Text] [PDF]

				A. W. Dreisbach, J. C. Rice, S. Japa, J. W. Newman, A. Sigel, R. S. Gill, A. E. Hess, A. C. Cemo, J. P. Fonseca, B. D. Hammock, et al. Salt Loading Increases Urinary Excretion of Linoleic Acid Diols and Triols in Healthy Human Subjects Hypertension, March 1, 2008; 51(3): 755 - 761. [Abstract] [Full Text] [PDF]

				C. Roberge, A. C. Carpentier, M.-F. Langlois, J.-P. Baillargeon, J.-L. Ardilouze, P. Maheux, and N. Gallo-Payet Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1465 - E1478. [Abstract] [Full Text] [PDF]

				P. Korantzopoulos, M. Elisaf, and H. J. Milionis Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease ready for prime time? Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2768 - 2774. [Full Text] [PDF]

				G. Colussi, C. Catena, R. Lapenna, E. Nadalini, A. Chiuch, and L. A. Sechi Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients Diabetes Care, September 1, 2007; 30(9): 2349 - 2354. [Abstract] [Full Text] [PDF]

				S. Kidambi, J. M. Kotchen, C. E. Grim, H. Raff, J. Mao, R. J. Singh, and T. A. Kotchen Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks Hypertension, March 1, 2007; 49(3): 704 - 711. [Abstract] [Full Text] [PDF]

				M. D. Payet, T. L. Goodfriend, L. Bilodeau, C. Mackendale, L. Chouinard, and N. Gallo-Payet An oxidized metabolite of linoleic acid increases intracellular calcium in rat adrenal glomerulosa cells Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1160 - E1167. [Abstract] [Full Text] [PDF]

				M. Nagase, S. Yoshida, S. Shibata, T. Nagase, T. Gotoda, K. Ando, and T. Fujita Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome: Possible Contribution of Fat-Derived Factors J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3438 - 3446. [Abstract] [Full Text] [PDF]

				M. Burnier The Renin-Angiotensin-Aldosterone System and Metabolic Syndrome Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 184 - 184. [PDF]

				M. Bochud, J. Nussberger, P. Bovet, M. R. Maillard, R. C. Elston, F. Paccaud, C. Shamlaye, and M. Burnier Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome Hypertension, August 1, 2006; 48(2): 239 - 245. [Abstract] [Full Text] [PDF]

				C. E. Grim, A. W. Cowley Jr, P. Hamet, D. Gaudet, M. L. Kaldunski, J. M. Kotchen, S. Krishnaswami, Z. Pausova, R. Roman, J. Tremblay, et al. Hyperaldosteronism and Hypertension: Ethnic Differences Hypertension, April 1, 2005; 45(4): 766 - 772. [Abstract] [Full Text] [PDF]

				S. Engeli, J. Bohnke, K. Gorzelniak, J. Janke, P. Schling, M. Bader, F. C. Luft, and A. M. Sharma Weight Loss and the Renin-Angiotensin-Aldosterone System Hypertension, March 1, 2005; 45(3): 356 - 362. [Abstract] [Full Text] [PDF]

				K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark Obesity-Associated Hypertension: New Insights Into Mechanisms Hypertension, January 1, 2005; 45(1): 9 - 14. [Abstract] [Full Text] [PDF]